Immix Biopharma, Inc. IMMX Deferred Tax Assets Depreciation
Deferred Tax Assets Depreciation at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept IMMX:DeferredTaxAssetsDepreciation.
The official record: Immix Biopharma, Inc.’s 10-K/A, filed March 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s deferred tax assets depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s deferred tax assets depreciation?
- Immix Biopharma, Inc. (IMMX) reported deferred tax assets depreciation of $20.96K in Q4 2025.
- What does deferred tax assets depreciation mean?
- This represents the deferred tax asset created by temporary differences between the depreciation methods used for financial reporting and those used for tax purposes. It indicates the future tax deductions available as the tax basis of assets exceeds their book value. This metric helps investors understand the timing of future tax cash outflows related to capital assets.